ReportWire

Tag: Flu

  • Cold season arrives in North Texas, and the flu is right around the corner

    Cases of influenza are starting to increase in North Texas, local doctors said, but aren’t above where we’d expect to be at this time of year.

    Cases of influenza are starting to increase in North Texas, local doctors said, but aren’t above where we’d expect to be at this time of year.

    U.S. Centers for Disease Control and Prevention

    Respiratory virus season has arrived in Fort Worth, and it’s infecting hundreds of North Texans with the common cold.

    “The most prevalent virus that we’re seeing right now is still the common cold,” said Dr. Kara Starnes, medical director of Cook Children’s Urgent Care. The common cold is typically caused by rhinoviruses.

    For the common cold, Starnes recommends the usual steps with dealing with respiratory viruses: Wash your hands often, cover your mouth when sneezing or coughing, and stay home when you’re sick.

    While the common cold remains prevalent, cases of influenza are also starting to increase, said Dr. Brian Byrd, the director of Tarrant County Public Health.

    “None of this is out of the expected increase,” Byrd said. “We’re tracking along right about where we normally do.”

    Both Byrd and Starnes urged people to get their annual flu shots.

    “We really want people to get a flu vaccine,” Starnes said. “The reason being, that prevents serious illness and hospitalization, especially for children.”

    The good news, Byrd said, is that this year’s flu vaccine is formulated to protect against the predominant flu strain — influenza A (H3N2) — that is circulating. The bad news, he said, is that the virus has mutated since the vaccine was created. But, even with the mutation, the vaccine is still very effective for keeping people out of the hospital.

    The number of children vaccinated against the flu has been steadily declining for the last several years, according to data from the U.S. Centers for Disease Control and Prevention. As of the end of November, only 38% of U.S. children between 6 months and 17 years were vaccinated, compared to 48% at the same time in 2019.

    Byrd said it was too soon to predict how severe this year’s flu season will be, but Starnes cautioned that the U.K.’s rough flu season could spell trouble for the U.S. if travelers spread the flu locally during the holiday season.

    Other countries have also had rough flu seasons. Australia had its worst flu season in recorded history, according to an Australian doctors’ group.

    Like the flu, RSV is also starting to increase, primarily in the pediatric population, Starnes and Byrd said. Respiratory syncytial virus, or RSV, is a typically seasonal virus that is most worrisome in children under 5, and particularly in infants. It is the most common cause of pneumonia and inflammation of small airways in the lungs for infants, according to the CDC. There is an RSV vaccine available for adults age 75 and older and for pregnant women.

    COVID-19 remains relatively quiet right now in North Texas.

    Related Stories from Fort Worth Star-Telegram

    Ciara McCarthy

    Fort Worth Star-Telegram

    Ciara McCarthy covers health and wellness as part of the Star-Telegram’s Crossroads Lab. She came to Fort Worth after three years in Victoria, Texas, where she worked at the Victoria Advocate. Ciara is focused on equipping people and communities with information they need to make decisions about their lives and well-being. Please reach out with your questions about public health or the health care system. Email cmccarthy@star-telegram.com or call or text 817-203-4391.

    Ciara McCarthy

    Source link

  • A new flu variant is spreading in Colorado as flu season heats up

    DENVER — ‘Tis the season — the flu season, that is.

    “It’s a great time to get together, and I’m sure people like to share joy, share peace. You don’t want to share germs, but we know that when there are gatherings, you know, there’s an uptick of cases,” said AdventHealth Southlands attending pediatrician Dr. Olukemi Akinrinola.

    Dr. Akinrinola has been busy with the recent increase in patients seeking treatment for influenza.

    “Influenza A, for sure, is more compared to last year,” she said.

    The latest data from the Colorado Department of Public Health and Environment (CDPHE) shows that 728 people in Colorado have been hospitalized with the flu since October 1, marking an earlier arrival to this year’s flu season. Nearly a quarter of those hospitalized so far have been children.

    CDPHE

    Dr. Ned Calonge, the chief medical officer of the CDPHE, put that data into context.

    “We know, for example, the overall rate of hospitalizations is about twice that as it was last year,” said Dr. Calonge.

    This year, a new variant — subclade K — is making the rounds, and seems to be particularly good at evading immunity conferred by this year’s flu vaccine.

    “This year’s vaccine was based on last year’s H3N2 [variant] and so there has been some evidence of a decreased activity against this year’s predominant strain,” he said.

    Dr. Calonge wants to make it clear though — you should still get your flu shot.

    “For kids, it’s keeping up to 75% of them from needing emergency care or hospitalization, and almost 40% of adults. So it demonstrates that the flu vaccine still is a very effective tool against the flu viruses this year,” he said.

    Twenty-five percent of Coloradans have gotten their flu shot, according to the latest state data.

    Wearing a high-quality mask like a N95 or KN95 in public settings, ventilating your home, handwashing, covering your cough, and seeking treatment early can all help stop the spread — and most importantly:

    “When you’re sick, stay away from people, because the next person may not be able to handle the condition as easily as you are handling them,” said Dr. Akinrinola.

    Coloradans making a difference | Denver7 featured videos


    Denver7 is committed to making a difference in our community by standing up for what’s right, listening, lending a helping hand and following through on promises. See that work in action, in the videos above.

    Adria Iraheta

    Source link

  • California braces for early, sharper flu season as virus mutation outpaces vaccine, experts say

    California could see an early start to the annual flu season, as a combination of low vaccination rates and late mutations to the virus may leave the state particularly exposed to transmission, health experts say.

    Already, there are warning signs. Los Angeles County recently reported its first flu death of the season, and other nations are reporting record-breaking or powerful, earlier-than-expected flu seasons.

    Typically, flu picks up right after Christmas and into the New Year, but Dr. Elizabeth Hudson, regional physician chief of infectious diseases at Kaiser Permanente Southern California, said she expects increases in viral activity perhaps over the next two to three weeks.

    “We’re expecting an early and likely sharp start to the flu season,” Hudson said.

    Last year’s flu season was the worst California had seen in years, and it’s not usual for there to be back-to-back bad flu seasons. But a combination of a decline in flu vaccination rates and a “souped-up mutant” is particularly concerning this year, according to Dr. Peter Chin-Hong, an infectious diseases expert at UC San Francisco.

    “That may translate into more people getting infected. And as more people get infected, a proportion of them will go to the hospital,” Chin-Hong said.

    The timing of this new flu subvariant — called H3N2 subclade K — is particularly problematic. It emerged toward the end of the summer, long after health officials had already determined how to formulate this fall’s flu vaccine, a decision that had to be made in February.

    H3N2 subclade K seems to be starting to dominate in Japan and Britain, Hudson said.

    “It looks like a bit of a mismatch between the seasonal flu vaccine strains” and the new subvariant, Hudson said.

    It remains unclear whether subclade K will reduce the effectiveness of this year’s flu shot.

    In California and the rest of the U.S., “things are quiet, but I think it’s just a calm before the storm,” Chin-Hong said. “From what we see in the U.K. and Japan, a lot more people are getting flu earlier.”

    Chin-Hong noted that subclade K is not that much different than the strains this year’s flu vaccines were designed against. And he noted data recently released in Britain that showed this season’s vaccines were still effective against hospitalization.

    According to the British government, vaccinated children were 70% to 75% less likely to need hospital care, and adults were 30% to 40% less likely. Flu vaccine effectiveness is typically between 30% to 60%, and tends to be more effective in younger people, the British government said.

    Even if there is some degree of mismatch between the vaccine and circulating strains, “the flu vaccine still provides protection against severe illness, including hospitalizations,” according to the Los Angeles County Department of Public Health.

    “Public Health strongly encourages everyone who has not received the flu vaccine yet this year to receive it now, especially before gathering with loved ones during the holidays,” the department said in a statement.

    But “while mismatched vaccines may still provide protection, enhanced genetic, antigenic and epidemiological … monitoring are warranted to inform risk assessment and response,” according to scientists writing in the Journal of the Assn. of Medical Microbiology and Infectious Diseases Canada.

    Because the vaccine is not a perfect match for the latest mutated flu strain, Chin-Hong said getting antiviral medication like Tamiflu to infected patients may be especially important this year, even for those who are vaccinated. That’s especially true for the most vulnerable, which include the very young and very old.

    “But that means you need to get diagnosed earlier,” Chin-Hong said. Drugs like Tamiflu work best when started within one to two days after flu symptoms begin, the U.S. Centers for Disease Control and Prevention says.

    There are now at-home flu testing kits that are widely available for sale for people who are showing signs of illness.

    Also worrying is how the flu has surged in other countries.

    Australia’s flu season came earlier this year and was more severe than usual. The Royal Australian College of General Practitioners said that nation saw a record flu season, with more than 410,000 lab-confirmed cases, up from the prior all-time high of 365,000 that were reported last year.

    “This is not a record we want to be breaking,” Dr. Michael Wright, president of the physician’s group, said.

    Hudson noted Australia’s flu season was “particularly hard on children” this year.

    L.A. County health officials cautioned that Australia’s experience isn’t a solid predictor of what happens locally.

    “It is difficult to predict what will happen in the United States and Los Angeles, as the severity of the flu season depends on multiple factors including circulating strains, pre-existing immunity, vaccine uptake, and the overall health of the population,” the L.A. County Department of Public Health said.

    The new strain has also thrown a wrench in things. As Australia’s flu season was ending, “this new mutation came up, which kind of ignited flu in Japan and the U.K., and other parts of Europe and Asia,” Chin-Hong said.

    On Friday, Japan reportedly issued a national alert with flu cases surging and hospitalizations increasing, especially among children and the elderly, accompanied by a sharp rise in school and class closures. The Japanese newspaper Asahi Shimbun said children ages 1 through 9 and adults 80 and up were among the hardest-hit groups.

    Taiwanese health officials warned of the possibility of a second peak in flu this year, according to the Central News Agency. There was already a peak in late September and early October — a month earlier than normal — and officials are warning about an uptick in flu cases starting in December and then peaking around the Lunar New Year on Feb. 17.

    Taiwanese officials said 95% of patients with severe flu symptoms had not been recently vaccinated.

    British health officials this month issued a “flu jab SOS,” as an early wave struck the nation. Flu cases are “already triple what they were this time last year,” Public Health Minister Ashley Dalton said in a statement.

    In England, outside of pandemic years, this fall marked the earliest start to the flu season since 2003-04, scientists said in the journal Eurosurveillance.

    “We have to brace ourselves for another year of more cases of flu,” Chin-Hong said.

    One major concern has been declining flu vaccination rates — a trend seen in both Australia and the United States.

    In Australia, only 25.7% of children age 6 months to 5 years were vaccinated against flu in 2025, the lowest rate since 2021. Among seniors age 65 and up, 60.5% were vaccinated, the lowest rate since 2020.

    Australian health officials are promoting free flu vaccinations for children that don’t require an injection, but are administered by nasal spray.

    “We must boost vaccination rates,” Wright said.

    In the U.S., officials recommend the annual flu vaccine for everyone age 6 months and up. Those age 65 and up are eligible for a higher-dose version, and kids and adults between age 2 and age 49 are eligible to get vaccinated via the FluMist nasal spray, rather than a needle injection.

    Officials this year began allowing people to order FluMist to be mailed to them at home.

    Besides getting vaccinated, other ways to protect yourself against the flu include washing your hands frequently, avoiding sick people and wearing a mask in higher-risk indoor settings, such as while in the airport and on a plane.

    Healthy high-risk people, such as older individuals, can be prescribed antiviral drugs like Tamiflu if another household member has the flu, Chin-Hong said.

    Doctors are especially concerned about babies, toddlers and young children up to age 5.

    “Those are the kids that are the most vulnerable if they get any kind of a respiratory illness. It can really go badly for them, and they can end up extraordinarily ill,” Hudson said.

    In the United States, just 49.2% of children had gotten a flu shot as of late April, lower than the 53.4% who had done so at the same point the previous season, according to preliminary national survey results. Both figures are well below the final flu vaccination rate for eligible children during the 2019-20 season, which was 63.7%.

    Among adults, 46.7% had gotten their flu shot as of late April, slightly down from the 47.4% at the same point last season, according to the preliminary survey results, which are the most recent data available.

    “Before the COVID-19 pandemic, flu vaccination coverage had been slowly increasing; downturns in coverage occurred during and after the pandemic. Flu vaccination levels have not rebounded to pre-pandemic levels,” according to the CDC.

    The disparaging of vaccinations by federal health officials, led by the vaccine-skeptic secretary of the U.S. Department of Health and Human Services, Robert F. Kennedy Jr., has not helped improve immunization rates, health experts say. Kennedy told the New York Times on Thursday that he personally directed the CDC to change its website to abandon its position that vaccines do not cause autism.

    Mainstream health experts and former CDC officials denounced the change. “Extensive scientific evidence shows vaccines do not cause autism,” wrote Daniel Jernigan, Demetre Daskalakis and Debra Houry, all former top officials at the CDC, in an op-ed to MS NOW.

    “CDC has been updated to cause chaos without scientific basis. Do not trust this agency,” Daskalakis, former director of the CDC’s National Center for Immunization and Respiratory Diseases, added on social media. “This is a national embarrassment.”

    State health officials from California, Washington, Oregon and Hawaii on Friday called the new claims on the CDC website inaccurate and said there are decades of “high quality evidence that vaccines are not linked to autism.”

    “Over 40 high-quality studies involving more than 5.6 million children have found no link between any routine childhood vaccine and autism,” the L.A. County Department of Public Health said Friday. “The increase in autism diagnoses reflects improved screening, broader diagnostic criteria, and greater awareness, not a link to vaccines.”

    Hudson said it’s important to get evidence-based information on the flu vaccines.

    “Vaccines save lives. The flu vaccine in particular saves lives,” Hudson said.

    Rong-Gong Lin II

    Source link

  • Flu activity is low, but experts worry about a new strain and vaccination rates

    By MIKE STOBBE and NICKY FORSTER

    NEW YORK (AP) — The U.S. flu season is starting slowly, and it’s unclear if it will be as bad as last winter’s, but some health experts are worried as U.S. Centers for Disease Control and Prevention data posted Friday shows a new version of the virus has emerged.

    The Associated Press

    Source link

  • Pfizer’s mRNA Flu Vaccine Works Great, but RFK Jr. Might Ruin It for Everyone

    Next-generation vaccines could make the flu season less of a snot-filled nightmare—if they ever reach the public, that is. Trial data out this week shows that Pfizer’s mRNA-based flu vaccine performed markedly better than a traditional shot.

    On Wednesday, researchers published the results of a Phase III trial on the vaccine, funded by Pfizer, in the New England Journal of Medicine. The experimental vaccine was significantly more effective at preventing flu than a standard vaccine, the researchers found. The vaccine appears to cause slightly more side effects than others, but there’s a bigger concern: It’s uncertain whether it will be approved in the U.S., given the government’s current skepticism and fearmongering around mRNA vaccine technology.

    Better but with a catch

    The trial involved more than 18,000 healthy adult volunteers in the U.S., South Africa, and the Philippines. It took place over the course of the 2022 to 2023 flu season. People were randomly assigned to receive a single dose of the experimental vaccine, dubbed modRNA, or Fluzone, a widely used inactivated flu vaccine made by Sanofi Pasteur. Both vaccines covered the four most common types of flu predicted to be circulating that season: two influenza A viruses and two influenza B viruses.

    There were noticeably fewer confirmed cases of influenza in the modRNA group compared to the control vaccine group (57 vs 87), the study showed. Overall, the modRNA vaccine was 34.5% more effective at preventing flu-like illness. The experimental vaccine also appeared to generate a higher antibody response to the influenza A strains and a similar response to the influenza B strains (nearly every confirmed flu case in the study was caused by influenza A).

    “This randomized trial showed that the modRNA vaccine provided both similar and improved prevention of a first episode of laboratory-confirmed influenza in adults between the ages of 18 and 64 years,” the study researchers wrote.

    That added protection may come with some tradeoffs, however. People given modRNA reported more local reactions (70.1% vs. 43.1%) after their shot, such as injection site pain. They were also more likely to report systematic adverse events in general, such as fever (5.6% vs 1.7%).

    This finding makes sense, since a vaccine’s adverse events are often linked to the immune response it generates. So a stronger immune response tends to cause more side effects. But while adverse events were more common in those who took modRNA, these events were still usually mild or moderate in severity. In the end, the study researchers concluded that the adverse event profiles of the two vaccines were similar.

    The RFK Jr. wrinkle

    All that said, the most serious hurdle to modRNA’s approval isn’t its potential side effects.

    Robert F. Kennedy Jr., the current U.S. Secretary of Health and Human Services, and his allies have systemically undermined vaccines during the second Trump administration. Just this week, for instance, the Centers for Disease Control and Prevention changed its website to boost the debunked myth that they cause autism. But as much as Kennedy and his buddies may mistrust vaccines in general, they have an especially strong hatred for mRNA vaccines, the newest type of vaccine that first saw wide use during the covid-19 pandemic.

    RFK Jr. has (wrongly) stated that the mRNA covid-19 shots developed by Pfizer and Moderna were the “deadliest” vaccines ever created, for instance. Anti-vaccination advocates have also falsely claimed that mRNA vaccines are gene therapies, that they make people magnetic, and that they’re causing an explosion in cases of “turbo cancer.”

    These unsupported fears of mRNA vaccines have had real-world consequences. In May, Moderna delayed the approval application for its combination flu/covid-19 vaccine (which also seemed to show greater protection against flu) after the FDA asked for more data. In August, RFK Jr. also pulled $500 million in federal funding for mRNA vaccine research and development.

    Contrary to claims from the anti-vaccination movement that mRNA vaccines are worse or more dangerous than other vaccines, this technology could actually strengthen our defenses against seasonal flu, and not just in terms of improved effectiveness. Since these vaccines typically take less time to tweak and produce than older types of vaccines, countries could wait longer to select the strains predicted to circulate during the season. That shortened lag could then prevent unexpected strains from causing a mismatch with the vaccine (a disastrous situation that’s now happening this winter).

    Moderna has said that it will seek approval for its stand-alone flu shot next year. And given these latest results, Pfizer will undoubtedly apply for approval of its modRNA vaccine, too. Typically, both vaccines would seem to have an excellent chance of approval. But nothing is typical these days.

    Ed Cara

    Source link

  • A new virus variant and lagging vaccinations may mean the US is in for a severe flu season

    The United States may be heading into its second severe flu season in a row, driven by a mutated strain called subclade K that’s behind early surges in the United Kingdom, Canada and Japan.Last winter’s season was extreme, too. The U.S. had its highest rates of flu hospitalizations in nearly 15 years. At least 280 children died of influenza, the highest number since pediatric death numbers were required to be shared in 2004.Now, with a new variant in the mix, experts say we’re on track for a repeat. And with flu vaccinations down and holiday travel on the way, they worry that things may look much worse in the weeks ahead.The good news: Early analysis shows that this season’s flu shots offer some protection against being hospitalized with this variant, especially for kids. The bad news is that many Americans appear to be skipping their flu vaccines this year. New data from prescription data company IQVIA shows that vaccinations are down compared to where they usually are at this point in the year.A new playerFlu activity is low but rising quickly in the United States, according to the latest FluView report from the U.S. Centers for Disease Control and Prevention.Most of the flu viruses identified this season have been an A strain called H3N2, and half of those have come from subclade K, a variant that was responsible for a rougher-than-normal flu season this summer in the Southern Hemisphere.That variant wasn’t a major player when scientists decided which strains should be in the annual flu shots, so the vaccines cover a related but slightly different group of viruses.”It’s not like we’re expecting to get complete loss of protection for the vaccine, but perhaps we might expect a little bit of a drop-off if this is the virus that sort of dominates the season, and early indications are that’s probably going to be the case,” said Dr. Richard Webby, director of the World Health Organization Collaborating Center for studies on the ecology of influenza in animals and birds at St. Jude Children’s Research Hospital.Early analysis by the U.K. Health Security Agency shows that subclade K has seven gene changes on a key segment of the virus. Those mutations change the shape of this region, making it harder for the body’s defenses to recognize.”That’s the predominant thing that our immune system targets with antibodies, and that’s also pretty much what’s in the vaccine,” said Dr. Adam Lauring, chief of the Division of Infectious Diseases at the University of Michigan Medical School.UKHSA scientists found that the current flu vaccines are still providing decent protection against subclade K viruses. Vaccination cut the odds of an emergency department visit or hospitalization for the flu by almost 75% in children. The effectiveness for adults, even those over 65, was lower, about 30% to 40% against needing to visit the hospital or ER.But the scientists offer a caveat: These results are from early in the season, before the protection from seasonal flu vaccines has had time to wane or wear off. The findings are posted in a recent preprint study, which means it was published ahead of scrutiny from outside experts.Still, some protection is better than no protection, and while subclade K is expected to dominate the season, it won’t be the only flu strain circulating. No one gets to pick what they’re exposed to. Lauring said his daughter has just recovered from the flu, but it was a B-type strain.At the same time this new variant has emerged, flu vaccinations appear to be down in the U.S. According to IQVIA, about 64% of all flu vaccinations were administered at retail pharmacies, which administered roughly 26.5 million flu shots between August and the end of October. That’s more than 2 million fewer shots than the 28.7 million given over the same time frame in 2024.”I’m not surprised,” said Dr. Jennifer Nuzzo, who directs the Pandemic Center at Brown University’s School of Public Health. Vaccine skepticism expressed by leaders of the US Department of Health and Human Services has “injected chaos into the whole vaccination system,” she said.”There’s been a lot of attention on really non-issues,” like vaccine ingredients and separating shots, that she thinks “at the best, left people confused but possibly at the worst have left people worried about getting vaccinated,” she added.Flu vaccinations have also fallen in Australia, where subclade K was the predominant virus this year. As a result, flu hit a record, with more than 443,000 cases. Flu season in the Southern Hemisphere typically runs from May to July, so infectious disease experts often look to those countries for a preview of what might be on the way to North America.”What they saw in Australia is that they had a bad season. And so it’s concerning for you and us, what’s coming,” said Dr. Earl Rubin, director of the infectious disease division at the Montreal Children’s Hospital in Canada.’This is the time we start to see the rise’It’s difficult to say whether subclade K actually makes a person sicker than other flu strains, but if it drives more cases, it will certainly drive hospitalizations too, Rubin said.”When you look at severity, the more cases you have, if the same percentage get hospitalized, obviously you’re going to have more hospitalization if you have more cases. So it sometimes will look like the severity is also worse,” he said.Lab testing data has begun to show an uptick in flu cases.”This is the time we start to see the rise,” said Dr. Allison McMullen, a clinical microbiologist at BioMerieux, which makes the BioFire test, a popular diagnostic tool for respiratory pathogens.The company anonymously compiles its test results into a syndromic surveillance tool, which can offer a glimpse of what bugs are making people sick at any given time. At the beginning of the month, less than 1% of tests were positive for type A flu. Now it’s 2.4% – still low numbers but going up briskly, which aligns with the CDC trend.”We’re going to start seeing heavy holiday travel before we know it,” McMullen added. “With the rising cases that we’re seeing the U.K. and Japan, it can definitely be a bellwether for what we’re going to see in North America.”Signals are also rising in wastewater, said Dr. Marlene Wolfe, an assistant professor of environmental health at Emory University. In October, 18% of samples in the WastewaterSCAN network — an academically led wastewater monitoring program based at Stanford University, in partnership with Emory — were positive for type A flu, Wolfe said. In November, that number had risen to 40%.”Flu is something where, when it’s not in season, we don’t detect it very frequently in wastewater,” Wolfe said. COVID, on the other hand, can be detected pretty much all the time, which makes it challenging to know if it’s going up or down, she said.The scientists can set a threshold for when they can declare that a specific area is in flu season, Wolfe says. So far, just four of the 147 sites they monitor in 40 states have reached that threshold. Those sites are in the Northeast — in Maine and Vermont — in Iowa and in Hawaii.”I am concerned, I guess, that we could have a big flu season this year based on what we’re seeing in other parts of the world, and particularly Europe and elsewhere,” Michigan’s Lauring said.”It’s not too late. Go and get your flu shot,” Lauring advised. “And be alert that it’s out there.”

    The United States may be heading into its second severe flu season in a row, driven by a mutated strain called subclade K that’s behind early surges in the United Kingdom, Canada and Japan.

    Last winter’s season was extreme, too. The U.S. had its highest rates of flu hospitalizations in nearly 15 years. At least 280 children died of influenza, the highest number since pediatric death numbers were required to be shared in 2004.

    Now, with a new variant in the mix, experts say we’re on track for a repeat. And with flu vaccinations down and holiday travel on the way, they worry that things may look much worse in the weeks ahead.

    The good news: Early analysis shows that this season’s flu shots offer some protection against being hospitalized with this variant, especially for kids. The bad news is that many Americans appear to be skipping their flu vaccines this year. New data from prescription data company IQVIA shows that vaccinations are down compared to where they usually are at this point in the year.

    A new player

    Flu activity is low but rising quickly in the United States, according to the latest FluView report from the U.S. Centers for Disease Control and Prevention.

    Most of the flu viruses identified this season have been an A strain called H3N2, and half of those have come from subclade K, a variant that was responsible for a rougher-than-normal flu season this summer in the Southern Hemisphere.

    That variant wasn’t a major player when scientists decided which strains should be in the annual flu shots, so the vaccines cover a related but slightly different group of viruses.

    “It’s not like we’re expecting to get complete loss of protection for the vaccine, but perhaps we might expect a little bit of a drop-off if this is the virus that sort of dominates the season, and early indications are that’s probably going to be the case,” said Dr. Richard Webby, director of the World Health Organization Collaborating Center for studies on the ecology of influenza in animals and birds at St. Jude Children’s Research Hospital.

    Early analysis by the U.K. Health Security Agency shows that subclade K has seven gene changes on a key segment of the virus. Those mutations change the shape of this region, making it harder for the body’s defenses to recognize.

    “That’s the predominant thing that our immune system targets with antibodies, and that’s also pretty much what’s in the vaccine,” said Dr. Adam Lauring, chief of the Division of Infectious Diseases at the University of Michigan Medical School.

    UKHSA scientists found that the current flu vaccines are still providing decent protection against subclade K viruses. Vaccination cut the odds of an emergency department visit or hospitalization for the flu by almost 75% in children. The effectiveness for adults, even those over 65, was lower, about 30% to 40% against needing to visit the hospital or ER.

    But the scientists offer a caveat: These results are from early in the season, before the protection from seasonal flu vaccines has had time to wane or wear off. The findings are posted in a recent preprint study, which means it was published ahead of scrutiny from outside experts.

    Still, some protection is better than no protection, and while subclade K is expected to dominate the season, it won’t be the only flu strain circulating. No one gets to pick what they’re exposed to. Lauring said his daughter has just recovered from the flu, but it was a B-type strain.

    At the same time this new variant has emerged, flu vaccinations appear to be down in the U.S. According to IQVIA, about 64% of all flu vaccinations were administered at retail pharmacies, which administered roughly 26.5 million flu shots between August and the end of October. That’s more than 2 million fewer shots than the 28.7 million given over the same time frame in 2024.

    “I’m not surprised,” said Dr. Jennifer Nuzzo, who directs the Pandemic Center at Brown University’s School of Public Health. Vaccine skepticism expressed by leaders of the US Department of Health and Human Services has “injected chaos into the whole vaccination system,” she said.

    “There’s been a lot of attention on really non-issues,” like vaccine ingredients and separating shots, that she thinks “at the best, left people confused but possibly at the worst have left people worried about getting vaccinated,” she added.

    Flu vaccinations have also fallen in Australia, where subclade K was the predominant virus this year. As a result, flu hit a record, with more than 443,000 cases. Flu season in the Southern Hemisphere typically runs from May to July, so infectious disease experts often look to those countries for a preview of what might be on the way to North America.

    “What they saw in Australia is that they had a bad season. And so it’s concerning for you and us, what’s coming,” said Dr. Earl Rubin, director of the infectious disease division at the Montreal Children’s Hospital in Canada.

    ‘This is the time we start to see the rise’

    It’s difficult to say whether subclade K actually makes a person sicker than other flu strains, but if it drives more cases, it will certainly drive hospitalizations too, Rubin said.

    “When you look at severity, the more cases you have, if the same percentage get hospitalized, obviously you’re going to have more hospitalization if you have more cases. So it sometimes will look like the severity is also worse,” he said.

    Lab testing data has begun to show an uptick in flu cases.

    “This is the time we start to see the rise,” said Dr. Allison McMullen, a clinical microbiologist at BioMerieux, which makes the BioFire test, a popular diagnostic tool for respiratory pathogens.

    The company anonymously compiles its test results into a syndromic surveillance tool, which can offer a glimpse of what bugs are making people sick at any given time. At the beginning of the month, less than 1% of tests were positive for type A flu. Now it’s 2.4% – still low numbers but going up briskly, which aligns with the CDC trend.

    “We’re going to start seeing heavy holiday travel before we know it,” McMullen added. “With the rising cases that we’re seeing the U.K. and Japan, it can definitely be a bellwether for what we’re going to see in North America.”

    Signals are also rising in wastewater, said Dr. Marlene Wolfe, an assistant professor of environmental health at Emory University. In October, 18% of samples in the WastewaterSCAN network — an academically led wastewater monitoring program based at Stanford University, in partnership with Emory — were positive for type A flu, Wolfe said. In November, that number had risen to 40%.

    “Flu is something where, when it’s not in season, we don’t detect it very frequently in wastewater,” Wolfe said. COVID, on the other hand, can be detected pretty much all the time, which makes it challenging to know if it’s going up or down, she said.

    The scientists can set a threshold for when they can declare that a specific area is in flu season, Wolfe says. So far, just four of the 147 sites they monitor in 40 states have reached that threshold. Those sites are in the Northeast — in Maine and Vermont — in Iowa and in Hawaii.

    “I am concerned, I guess, that we could have a big flu season this year based on what we’re seeing in other parts of the world, and particularly Europe and elsewhere,” Michigan’s Lauring said.

    “It’s not too late. Go and get your flu shot,” Lauring advised. “And be alert that it’s out there.”

    Source link

  • Missed your annual flu shot? Local doctor says: ‘Time to get it’ – WTOP News

    This year’s flu season may arrive later than usual, but that does not necessarily mean it will be mild. It does mean that it’s not too late to get your flu vaccine.

    There is no one-to-one correlation between cold weather and getting sick.

    That old adage about stepping outside and catching a cold does not tell the whole story. What does matter is that winter pushes people indoors and into closer contact, making it easier for viruses to spread.

    Children’s National Hospital infectious disease physician Dr. Alexandra Yonts told WTOP that this year’s flu season may arrive later than usual, but that doesn’t necessarily mean it will be mild.

    She warned flu cases could start climbing “after Christmas and New Year’s,” when people travel and families gather.

    “Last year, almost 300 children died from influenza, and most of (them) were previously healthy,” Yonts said.

    She said one reason the flu shot remains essential is for protecting people with respiratory illnesses, existing health conditions or weakened immune systems.

    And no, the flu shot cannot give you the flu.

    “In common vocabulary, we throw around the term ‘flu’ to mean any sort of viral illness that gives us a fever. But there are hosts of other viruses that are not covered by the influenza vaccine that can still make you sick,” she said. “Protecting you against influenza specifically is still a priority.”

    Yonts added that getting vaccinated is especially important before visiting young children, elderly relatives or immunocompromised family members during the holidays.

    “Think of it as doing it for those people, if you aren’t interested in doing it just for yourself,” she said.

    If you’re behind, Yonts said getting both the flu shot and the updated COVID booster at the same visit is completely safe: “That has been studied, and it shows there’s no major difference in the side effects. If anything, you’re getting them both out of the way at once.”

    Flu shots are recommended for those 6 months old and older, and doctors say it takes about two weeks to build full immunity.

    Get breaking news and daily headlines delivered to your email inbox by signing up here.

    © 2025 WTOP. All Rights Reserved. This website is not intended for users located within the European Economic Area.

    Abigail Constantino

    Source link

  • A Surprise Flu Variant Threw Off the Vaccine. Get Ready for a Brutal Winter

    Scientists are sounding the alarm: this winter’s upcoming flu season in North America could be a real nightmare, thanks to the rapid arrival of a variant that doesn’t match well with the seasonal flu vaccine.

    Health officials in Canada issued the warning in a paper late last month. An unexpected variant of the H3N2 flu, dubbed subclade K, quickly emerged during the tail end of the flu season in the Southern Hemisphere this year, they noted. Subclade K is now poised to become one of the most dominant variants of the flu season in the U.S. and Canada, and it’s likely that our vaccines will be less effective overall this winter against the flu than experts had predicted.

    “While mismatched vaccines can still provide protection against circulating variants, enhanced surveillance is warranted,” the researchers wrote in their paper, published in the Journal of the Association of Medical Microbiology and Infectious Disease Canada.

    A drifting mismatch

    During the peak of a flu season, multiple variants of influenza A and influenza B viruses will spread between people.  Because it takes about nine months to ramp up enough vaccines for everyone in a given hemisphere, scientists and health authorities meet twice a year (once for the northern half, once for the southern) to predict which variants are most likely to circulate in the population, and thus, which variants a seasonal flu vaccine should cover. Part of this educated guesswork comes from tracking the flu strains moving across the globe at that time.

    Usually, the predictions aren’t too far off, and the vaccines will provide at least moderate protection from illness. But flu viruses are always evolving, and variants can gradually develop mutations (a process called drift) that make them significantly different from what scientists had expected them to look like. That seems to be what’s happened here with the latest versions of H3N2, a type of influenza A.

    According to the researchers, an increasing amount of H3N2 variants with concerning mutations emerged during last winter’s flu season in the northern hemisphere. These variants are perhaps one major reason why the U.S. experienced such a hard-hitting flu this past winter.

    More recently, a further drifted and poorly matched lineage of H3N2—subclade K—emerged toward the end of the winter in the Southern Hemisphere. This lineage is now “projected to predominate among A(H3N2) viruses for the NH 2025–2026 season,” the researchers wrote.

    The possibility remains that subclade K will not spread widely in North America, since there will be other circulating variants of flu around at the same time. But the odds of that aren’t looking too good. In the UK, health officials have already announced an early start to its flu season, with a majority of these cases being caused by subclade K. Hospitals in the region are now preparing for a big surge of flu.

    It’s also worth wondering whether the fractured state of public health in the U.S. will further hamper efforts to contain the flu. President Donald Trump and Health Secretary Robert F. Kennedy Jr. have overseen dramatic funding cuts and layoffs throughout the Centers for Disease Control and Prevention and other health agencies this year, while RFK Jr. has fired or pressured senior health officials to leave the CDC.

    Why vaccines still matter

    Despite the dire outlook, vaccines remain one of the most important tools against the flu this season. There are other strains of flu that the vaccine will cover, and a mismatched vaccine can still provide some protection against the worst outcomes of flu, which can include death. Thankfully, there is good news on that front.

    This week, the UK Health Security Agency reported the latest data from its flu surveillance program. Even with a mismatched variant in the picture, the vaccine is currently estimated to be 70% to 75% effective at preventing flu hospitalizations in children and 30% to 40% effective in adults.

    “These results provide reassuring evidence that this season’s flu vaccines currently offer important protection to children and adults, despite concerns about the new subclade,” said Jamie Lopez Bernal, consultant epidemiologist for Immunization at UKHSA, in a statement from the agency.

    So it’s still worthwhile to get your flu shot as soon as you can. But given the mismatch this winter, it’s all the more important to practice good hygiene, to stay home if you’re sick, and to potentially wear a mask in higher-risk situations for added protection (well-fitting, high-quality masks such as a KN95 or N95 being the most effective).

    Ed Cara

    Source link

  • Herbal Roll-on Remedies for Headache, Sleep, and Cold & Flu – Garden Therapy

    Whenever I feel a little under the weather or sense that I’m coming down with something, these essential oil roll-on remedies are the first thing I turn to. These essential oil roll-on recipes are super simple to put together and really work. I’ll show you my favourite recipes to help relieve symptoms from headache, insomnia, and cold and flu viruses naturally! 

    Roll-on remedies are a quick and natural first line of defense against common (yet super annoying) ailments: headaches, disrupted sleep, and cold and flu viruses. They are made with high concentrations of herbs and essential oils in a gentle dilution of carrier oil that is convenient to use.

    Today, I’ll share the three essential oil roll-on recipes that I turn to so I can avoid popping pills.

    This post will cover…

    fresh-cut herbsfresh-cut herbs
    Herbs have many different healing properties, depending on which you choose.

    Do Roll-On Remedies Work?

    In a word…yes!

    Somehow, I’m always surprised at the effectiveness of my homemade roll-on remedies. Even though I use a lot of essential oils and remedies on myself and with my family, I still have the tiniest jolt of awe every time they work.

    And why shouldn’t they? Herbal healing has been around for longer than me, or you, or Western Medicine, for that matter. The power of plants is something that you can easily harness into a pocket-sized roll-on bottle to help with little ailments before they get out of control.

    iHerb Online Order of Essential OilsiHerb Online Order of Essential Oils
    I include essential oils in many of my recipes both for their scent and herbal properties.

    Selecting Essential Oil for Your Roll-On Recipes

    Before I give you the recipes for my roll-on remedies, I want to share a little about essential oil brands. I’m not affiliated with any essential oil network marketing companies and, to be honest, I’ve only tried a few of the products they offer.

    Over the years, I have tried a large number of brands from traditional stores, though, and I like to shop around for different brands to experiment with. I use my nose and other senses to evaluate how the oils work for me.

    I have researched and even chatted with the makers of a number of brands and have learned two things:

    1. There is no certification or industry standard for essential oil brands, meaning the quality of the products is all over the map.
    2. More expensive oils are not necessarily better. Some brands that have high price points have far inferior products than those with lower price points. Yes, ingredients are one reason for the price of the bottle, but that number is also influenced by marketing, customer demand, and supply scale, among other things. I used to bypass the inexpensive essential oils brands, thinking that they were of poor quality, when in fact the price of some brands is low because they produce so much that they are able to gain more economies of scale.
    essential oil bottles and fresh herbs and spicesessential oil bottles and fresh herbs and spices
    Do your research to ensure your essential oils are of good quality.

    Are Roll-On Essential Oils Safe?

    Essential oils are compounds extracted from plants, meaning they are supercharged with the plant’s aromas and herbal benefits. They’re potent and strong, one of my favourite herbal ingredients, and completely safe for use when used right.

    When using essential oil roll-ons, it’s important to get the dose right. Typically, you never want to place pure essential oil directly on the skin. That is why I dilute it with a high-quality carrier oil to make it completely safe for skin application. Certain essential oils should also be avoided for skin use, such as cinnamon bark and oregano.

    And as mentioned above, you want to make sure you’re using high-quality essential oils. So do your research into any brand before buying, regardless of price point. This will make certain that you’re actually getting results from your roll-on oil!

    Grapeseed oil as a career oil for essential oilsGrapeseed oil as a career oil for essential oils
    Essential oils will need carrier oils to be safely applied to the skin.

    How to Use an Essential Oil Roll-On

    I made three of my favourite roll-on remedies from the essential oils, and I used grapeseed oil as the carrier oil to dilute them.

    To apply your roll-on oil, make sure to perform a patch test beforehand to see how your skin will react. To do this, wash your forearm with soap and pat it dry. Roll on your essential oil remedy and wait 24 hours to see if there is any kind of reaction.

    I apply every one of my roll-on essential oils differently. Some I like on my face, behind my ears, on my chest, and even on the bottom of my feet. I noted for each roll-on oil how I like to use it, but experiment for yourself. Just make sure to keep the oils far enough away from your eyes!

    So let’s put these oils to good use, shall we?

    Headache Roll On RemedyHeadache Roll On Remedy

    Headache Relief Roll-on Remedy

    Add the drops of essential oil into the roller bottle and fill with grapeseed oil, leaving a bit of headspace for the roller cap. Pop the roller into the bottle and add the cap.

    How to Use

    When I first feel a headache coming on, I use this roll-on for headaches by creating a halo around my head. Rolling it around my hairline from my forehead to temple, around the nape of my neck, and back up to the starting point. If I catch a headache before it gets momentum, this remedy will help take it away.

    Sleep Well Roll-on Remedy

    Add the drops of essential oil into the roller bottle and fill with grapeseed oil, leaving a bit of headspace for the roller cap. Pop the roller into the bottle and add the cap.

    How to Use

    I apply this remedy before bed to help promote restful sleep. To use, I roll it behind my ears, the back of my neck, and the soles of my feet. I also apply hand and foot lotion at night, so I roll the ball in the palm of my hand, mix it in with the lotion, and then rub it into my hands and feet.

    Cold and Flu Roll On RemedyCold and Flu Roll On Remedy

    Cold and Flu Roll-on Remedy

    Add the drops of essential oil into the roller bottle and fill with grapeseed oil, leaving a bit of headspace for the roller cap. Pop the roller into the bottle and add the cap.

    This one has a lot more ingredients, but every drop is worth its weight in gold! Having gone through every single virus the last few years that my son was in daycare, I stopped getting 80% of them when I started using this combination.

    How to Use

    I apply this remedy in cold and flu season and when there is a virus going around. Usually, I roll it on my chest and the soles of my feet. I also use it as a hand sanitizer when I’m out in public and can’t wash my hands.

    Herbal Roll on Remedy with RosemaryHerbal Roll on Remedy with Rosemary
    Thanks to their small size, you can bring these remedies with you on the go.

    For fun, I added some fresh herbs to my essential oil roll-ons to help me identify them. I added a tip of young rosemary to the cold and flu remedy, and a few small peppermint leaves to the roll-on for headaches.

    I also added small lavender flowers on the stem, plus some purple Centaurea Classic Artist Mix petals (because lavender doesn’t hold its colour in oil, but Centaurea does) to the sleep remedy.

    Herbal Roll on remedies with herbs
    Add fresh or dried botanicals for appearance.

    But…you can go a bit more traditional by using a label maker to identify the name of each of the essential oil roll-on recipes, too.

    Roll on Remedies Head Aid Sleep Well and Immunity BoostRoll on Remedies Head Aid Sleep Well and Immunity Boost
    Add labels, especially if you plan on gifting these remedies.

    Either way, you’ll be sure to love these fantastic essential oil roll-ons. I recommend mixing them up so they are ready for you the next time you feel symptoms coming on. You’ll be thankful you did!

    More Ways to Use Essential Oils

    Stephanie Rose

    Source link

  • CDC vaccine advisory panel changes guidance for COVID-19 shots

    DENVER — The Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices declined to recommend the COVID-19 vaccine to anyone, even those at high risk, leaving people to choose for themselves whether to get it.

    Until now, COVID-19 vaccinations had been recommended as a routine shot each fall, like a flu vaccine.

    The advisors also urged the CDC to adopt stronger language around claims of vaccine risks, despite pushback from outside medical groups that say the shots have a proven safety record from billions of doses administered worldwide.

    The Associated Press reports that among many unproven questions about risks that the panel raised Friday was one rare side effect that people already are warned about: a kind of heart inflammation called myocarditis, mostly in young men, that was discovered in the early days of vaccination in 2021. A scientist studying whether people with certain genes are uniquely susceptible to that risk told the panel the Trump administration had canceled his grant before the research could be finished.

    The divided panel narrowly avoided urging states to require a prescription for the COVID-19 shot.

    What is the CDC’s vaccine advisory panel and why is it so influential?

    On Thursday, the panel voted to change its age recommendations for the measles, mumps, rubella and varicella (MMRV) vaccine.

    In an 8-3 vote, the panel decided to change the recommended minimum age for receiving the MMRV vaccine, which combines the MMR vaccine and the chickenpox vaccine, to 4 years old, and that children in this age group instead get separate vaccines — one against MMR and another for varicella, or chickenpox.

    Since 2009, the CDC has said it prefers separate shots for initial doses of those vaccines, and 85% of toddlers already do.

    In a move that surprised some medical groups, the panel delayed recommending whether to end the longstanding CDC recommendation that all newborns be vaccinated at birth against the liver virus, hepatitis B.

    The Associated Press reports that the panel had been considering whether to recommend delaying that initial vaccination — something doctors and parents already can choose to do. However, amid criticism from independent pediatric and infectious disease specialists who say the vaccine is safe and has helped infant infections drop sharply, the advisers decided Friday to postpone that decision.

    Scripps News Group and the Associated Press contributed to this report.

    Denver7

    Denver7 | Your Voice: Get in touch with Shannon Ogden

    Denver7 evening anchor Shannon Ogden reports on issues impacting all of Colorado’s communities, but specializes in covering local government and politics. If you’d like to get in touch with Shannon, fill out the form below to send him an email.

    Shannon Ogden

    Source link

  • Doctor explains a rare but serious condition associated with the flu

    We all know that influenza is a common and serious viral infection, but it’s good to be reminded ahead of the upcoming flu season, which typically starts in October.Related video above: How the new at-home flu vaccine worksThere were an estimated 47 million to 82 million flu illnesses in the United States between October 2024 and May 2025, resulting in between 610,000 and 1.3 million hospitalizations, according to preliminary estimated ranges from the U.S. Centers for Disease Control and Prevention.Most fatalities occur in older individuals, but children can also die from the flu. The CDC estimates that flu-related deaths in children have generally ranged from 37 to 199 deaths each flu season.Now, a new study in JAMA has examined a rare but severe complication that can occur in children who contract the flu. This complication, called acute necrotizing encephalopathy, or ANE, carries a mortality rate of 27% despite intensive care and treatment, according to the new research.I wanted to learn more about complications associated with the flu, specifically about ANE, what researchers learned about children with ANE, and how ANE can be prevented. And what should parents and families know ahead of the next flu season?To help with these questions, I spoke with CNN wellness expert Dr. Leana Wen. Wen is an emergency physician and clinical associate professor at George Washington University. She previously was Baltimore’s health commissioner.CNN: What are complications associated with the flu? Who is most at risk?Dr. Leana Wen: Most people who have the flu will recover without complications. They may go through days or even weeks having fever, runny nose, headache and fatigue, but these symptoms generally resolve without long-term consequences.Some people, though, experience complications that could result in severe illness or even death. These complications include pneumonia, sinus and ear infections, brain and neurological conditions, and the worsening of existing medical problems such as heart and kidney disease.People at higher risk for flu complications include people 65 years and older, children younger than 2 and pregnant women. In addition, there are a variety of chronic medical conditions that increase risk, including chronic lung disease, diabetes, heart disease, liver disorders, kidney dysfunction and any condition that makes you immunocompromised.CNN: What exactly is ANE, and how common is it?Wen: ANE is a rare but very serious condition that occurs as a result of influenza infection. It causes inflammation and swelling in the brain, and it can lead to seizures, impaired consciousness, coma, long-term brain damage and death.It’s not known precisely how common this condition is or whether the incidence has been changing in recent years. It can also occur after other viral illnesses, but it has been most closely associated with influenza, and most often in children.CNN: What did researchers in this study find out about children with ANE?Wen: They sought information from U.S. pediatric hospitals and public health agencies regarding cases of pediatric ANE treated between October 2023 and May 2025. In total, they included 41 children with influenza-related ANE.The median age of these children was 5, and about 3 out of 4 were previously healthy. Importantly, just 16% of those for whom vaccination history was available had received the flu vaccine that season.All these patients became very ill, and all developed encephalopathy, or altered brain function. Sixty-eight percent had seizures. Most had abnormalities in their platelet count, liver enzymes and spinal fluid composition.Most patients received a combination of therapies, including steroids and immunoglobulins. Out of 41 patients in the analysis, 11 died. The median period between symptom onset and death was just three days; most of the children who died had such severe brain swelling that the pressure forced the brain downward, crushing vital areas that control breathing and heart function. All but one of the children who died had not received the latest flu vaccine. Among the survivors included in the analysis, 63% had at least moderate disability.The first takeaway for me is that ANE, while rare, is extremely serious, with high morbidity and mortality. It can be deadly within a short period of time, which means prompt diagnosis and treatment are essential. Second, most children with ANE were previously healthy. Third, while some vaccinated children also became ill, most of those with ANE and nearly all of those who died had not received the flu vaccine that season.CNN: How can ANE be prevented?Wen: It is not known why most people who contract flu never develop ANE, but some do. It’s also not known whether there is anything that can be done once someone contracts the flu to prevent ANE.What is known is that getting the flu vaccine reduces the chance of contracting the flu and of becoming severely ill as a result. This JAMA study also suggests that vaccination reduces the likelihood of developing ANE and of dying from it. The article and an accompanying editorial emphasize the importance of everyone being up-to-date with the flu vaccine.CNN: What else should parents and families know ahead of the next flu season?Wen: Influenza is a common illness that can have serious complications, including in previously healthy individuals. Getting the flu vaccine is helpful both for reducing the chance of contracting the flu and for lowering the likelihood of developing complications. The CDC recommends the flu vaccine for virtually everyone 6 months and older. Parents should be sure that their children receive the flu vaccine in the fall and that they and others in the family are vaccinated, too.Of course, flu is not the only contagious respiratory illness that can spread in fall and winter months. It’s important for people who have fever and active respiratory symptoms to stay away from others, especially those most vulnerable to severe illness. Good hand hygiene can lower the risk of spreading contagious diseases, as can taking precautions like masking in indoor crowded settings.

    We all know that influenza is a common and serious viral infection, but it’s good to be reminded ahead of the upcoming flu season, which typically starts in October.

    Related video above: How the new at-home flu vaccine works

    There were an estimated 47 million to 82 million flu illnesses in the United States between October 2024 and May 2025, resulting in between 610,000 and 1.3 million hospitalizations, according to preliminary estimated ranges from the U.S. Centers for Disease Control and Prevention.

    Most fatalities occur in older individuals, but children can also die from the flu. The CDC estimates that flu-related deaths in children have generally ranged from 37 to 199 deaths each flu season.

    Now, a new study in JAMA has examined a rare but severe complication that can occur in children who contract the flu. This complication, called acute necrotizing encephalopathy, or ANE, carries a mortality rate of 27% despite intensive care and treatment, according to the new research.

    I wanted to learn more about complications associated with the flu, specifically about ANE, what researchers learned about children with ANE, and how ANE can be prevented. And what should parents and families know ahead of the next flu season?

    To help with these questions, I spoke with CNN wellness expert Dr. Leana Wen. Wen is an emergency physician and clinical associate professor at George Washington University. She previously was Baltimore’s health commissioner.

    CNN: What are complications associated with the flu? Who is most at risk?

    Dr. Leana Wen: Most people who have the flu will recover without complications. They may go through days or even weeks having fever, runny nose, headache and fatigue, but these symptoms generally resolve without long-term consequences.

    Some people, though, experience complications that could result in severe illness or even death. These complications include pneumonia, sinus and ear infections, brain and neurological conditions, and the worsening of existing medical problems such as heart and kidney disease.

    People at higher risk for flu complications include people 65 years and older, children younger than 2 and pregnant women. In addition, there are a variety of chronic medical conditions that increase risk, including chronic lung disease, diabetes, heart disease, liver disorders, kidney dysfunction and any condition that makes you immunocompromised.

    CNN: What exactly is ANE, and how common is it?

    Wen: ANE is a rare but very serious condition that occurs as a result of influenza infection. It causes inflammation and swelling in the brain, and it can lead to seizures, impaired consciousness, coma, long-term brain damage and death.

    It’s not known precisely how common this condition is or whether the incidence has been changing in recent years. It can also occur after other viral illnesses, but it has been most closely associated with influenza, and most often in children.

    CNN: What did researchers in this study find out about children with ANE?

    Wen: They sought information from U.S. pediatric hospitals and public health agencies regarding cases of pediatric ANE treated between October 2023 and May 2025. In total, they included 41 children with influenza-related ANE.

    The median age of these children was 5, and about 3 out of 4 were previously healthy. Importantly, just 16% of those for whom vaccination history was available had received the flu vaccine that season.

    All these patients became very ill, and all developed encephalopathy, or altered brain function. Sixty-eight percent had seizures. Most had abnormalities in their platelet count, liver enzymes and spinal fluid composition.

    Most patients received a combination of therapies, including steroids and immunoglobulins. Out of 41 patients in the analysis, 11 died. The median period between symptom onset and death was just three days; most of the children who died had such severe brain swelling that the pressure forced the brain downward, crushing vital areas that control breathing and heart function.

    All but one of the children who died had not received the latest flu vaccine. Among the survivors included in the analysis, 63% had at least moderate disability.

    The first takeaway for me is that ANE, while rare, is extremely serious, with high morbidity and mortality. It can be deadly within a short period of time, which means prompt diagnosis and treatment are essential. Second, most children with ANE were previously healthy. Third, while some vaccinated children also became ill, most of those with ANE and nearly all of those who died had not received the flu vaccine that season.

    CNN: How can ANE be prevented?

    Wen: It is not known why most people who contract flu never develop ANE, but some do. It’s also not known whether there is anything that can be done once someone contracts the flu to prevent ANE.

    What is known is that getting the flu vaccine reduces the chance of contracting the flu and of becoming severely ill as a result. This JAMA study also suggests that vaccination reduces the likelihood of developing ANE and of dying from it. The article and an accompanying editorial emphasize the importance of everyone being up-to-date with the flu vaccine.

    CNN: What else should parents and families know ahead of the next flu season?

    Wen: Influenza is a common illness that can have serious complications, including in previously healthy individuals. Getting the flu vaccine is helpful both for reducing the chance of contracting the flu and for lowering the likelihood of developing complications. The CDC recommends the flu vaccine for virtually everyone 6 months and older. Parents should be sure that their children receive the flu vaccine in the fall and that they and others in the family are vaccinated, too.

    Of course, flu is not the only contagious respiratory illness that can spread in fall and winter months. It’s important for people who have fever and active respiratory symptoms to stay away from others, especially those most vulnerable to severe illness. Good hand hygiene can lower the risk of spreading contagious diseases, as can taking precautions like masking in indoor crowded settings.

    Source link

  • Can Cannabis Help During Flu Season

    Can Cannabis Help During Flu Season

    The cold weather is arriving and with it comes flu season…but maybe a type of cannabis can help.

    The days are getting shorter and the weather a bit more difficult. Which drives people indoors and provides a great chance of catching something – like the flu. People packed together along with cold, dry air, which can weaken resistance, make it easier to catch the virus. But can cannabis help during flu season? As interest in natural remedies grows, many are exploring cannabis as a complementary option for managing discomfort during illness.

    Studies show cannabis contains compounds with anti-inflammatory properties, which some believe could help alleviate flu symptoms. It can also help manage flu symptoms like pain, nausea, and loss of appetite. A key factor is how to consume and the dosage amount.  Smoking, including vaping, can aggravate the virus and the lungs.  The most soothing way would be via edibles, like gummies, or tincture/oils.
    Photo by Tinnakorn Jorruang/Getty Images

    Pain Relief – Cannabinoids like THC and CBD have analgesic properties that may help alleviate body aches and headaches associated with the flu. By binding to pain receptors, cannabis can reduce the perception of pain and provide comfort.

    Anti-Inflammatory Effects – The flu triggers inflammation as part of the immune response. CBD, in particular, is known for its potent anti-inflammatory properties, This may help reduce swelling and discomfort in the respiratory tract.

    Sleep Aid – Getting adequate rest is crucial for recovery. Cannabis, especially strains high in THC, can have sedative effects that may help those struggling with flu-related insomnia

    Appetite Stimulation – The “munchies” effect of cannabis could be beneficial for flu patients experiencing reduced appetite. Maintaining proper nutrition is important for the body’s healing process.

    Interestingly, some research indicates that cannabis may offer temporary respiratory relief.  It might help with bronchodilatation. Infrequent cannabis use has been shown to open airways for 15-60 minutes, potentially easing shortness of breath. Cannabis may act as an expectorant, helping to clear phlegm from the lungs and throat.

    Cannabis may offer a natural approach to managing some flu symptoms, particularly pain, inflammation, and sleep disturbances. However, it’s not a replacement for proper medical care, hydration and rest. As research continues, there will develop a clearer understanding of how cannabis interacts with the immune system during viral infections. Always talk with a health professional if you have flu or flu like symptoms.

    Amy Hansen

    Source link

  • Can Cannabis Or Alcohol Help With Colds

    Can Cannabis Or Alcohol Help With Colds

    The weather is turning cold, wet and soon snowy – it is the winter cold season – does marijuana or booze help or hurt?

    October is when the weather turns and head colds appear in force. There are reasons for it, more time indoors during the colder months, which makes it easier for viruses to spread is a key reason. Also, cold, dry air can make nasal passages more vulnerable to infection. It is heard to avoid, but there are some thing you can do to avoid them and still have fun! Washing your hands, keep work and home surfaces clean, get enough sleep and eat healthy are all helpful.  But can cannabis or alcohol help with colds?

    RELATED: 5 Morning Activities To Help You Feel Happier

    While both marijuana and booze are seen as “bad” and “vices”, there are reasons to consider them as a helpmate during cold season. The average adult will get 2 to 4 colds a year, mainly in the fall and winter months. The symptoms including a stuffy runny nose, sore throat, sneezing, fever and a cough…it makes it miserable.  But beyond a bracing hot toddy…can a couple of vices help?

    Photo by Jamie Grill/Getty Images

    Alcohol does not make it easier to catch a cold. In fact, there is some evidence moderate alcohol consumption may actually reduce the frequency of colds. However, excessive alcohol use can negatively impact the immune system and potentially increase susceptibility to infections.

    Some studies suggest moderate alcohol intake may decrease the number of colds people get overall. For example, one study found that participants who consumed 11.5 to 35.8 grams of alcohol per day (equivalent to about 1-3 standard drinks) experienced fewer episodes of the common cold compared to non-drinkers.

    The potential protective effect may be due to alcohol’s influence on certain aspects of the immune response, such as the release of inflammatory cytokines, which could be beneficial for fighting infections in the short term/

    Occasional or moderate drinking may have some benefits but excessive or frequent alcohol use can negatively impact the immune system and overall health. Alcohol can weaken the immune system’s ability to fight off infections. It can alter gut flora, damage the intestinal lining, and impair immune cell function in the respiratory tract, increasing vulnerability to infections. And it can lead you to dehydration if you are not careful.

    The biggest thing is alcohol may help before you catch a cold, but not after you catch one.

    Marijuana can’t help you avoid a cold, but it can help you manage the symptoms. Cannabis, particularly CBD, has anti-inflammatory properties that could help reduce inflammation associated with colds. THC and CBD may help relieve body aches and headaches that often accompany colds. Cannabis can promote sleep, which is important for recovery when sick

    And THC can help stimulate appetite, which may be beneficial when feeling unwell

    RELATED: This Epic Love Story Is Being Set To Music

    A cold can be caused by a number of different viruses, including rhinoviruses, parainfluenza, and seasonal coronaviruses. There is no cure for the common cold, but there are ways to treat symptoms and feel better while your body fights it off.  Get plenty of rest, hydrate, use humidifiers or team to help the throat and eat well.

    Amy Hansen

    Source link

  • Stay ahead this flu season: California health experts urge timely vaccinations

    Stay ahead this flu season: California health experts urge timely vaccinations

    Stay ahead this flu season: California health experts urge timely vaccinations

    The ideal time for the flu vaccine is before the end of October.

    EXPERTS ON WHAT YOU SHOULD KNOW. CIRCULATING EVERY YEAR. A NASTY VIRUS FOR SOME AND DEADLY FOR OTHERS. INFLUENZA BEGINNING TO MAKE ITS ROUNDS. TYPICALLY, THE FLU STARTS IN THE FALL AND CAN ABSOLUTELY GO ALL THROUGH THE WINTER INTO THE SPRING AND SOMETIMES WE’VE SEEN INFLUENZA LAST ALL THE WAY THROUGH TO MAY. SPEAKING TO DOCTOR VANESSA WALKER, SHE SAYS RIGHT NOW WE’RE STILL BEATING THE CURVE. WE’RE NOT REALLY SEEING MUCH FLU AT ALL YET IN THE HOSPITALS OR OUT IN THE COMMUNITY. IT’S STILL AT VERY LOW LEVELS RIGHT NOW, WHICH LEADS TO THE FACT THAT WE ARE IN THE PERFECT WINDOW OF TIME TO GET THE VACCINE. I USUALLY RECOMMEND THAT YOU IF YOU’RE GOING TO GET THE FLU VACCINE, THAT YOU SHOULD PROBABLY GET IT BEFORE THE END OF OCTOBER. THAT’S WHEN YOU’RE GOING TO GET IT. IT TAKES A COUPLE WEEKS FOR IT TO REALLY GET TO FULL EFFICACY FOR YOUR BODY TO MAKE ALL THOSE FLU ANTIBODIES, TO REALLY PROTECT YOU. GETTING THE VACCINE NOW ENSURES YOU’RE COVERED THROUGH PEAK FLU SEASON, WHICH TYPICALLY LANDS NEAR THE HOLIDAYS. GETTING IT TOWARDS THE END OF OCTOBER SHOULD START COVERING YOU WHEN WE START TO SEE MORE FLU CASES IN THE FALL, AND THEN WE’LL DEFINITELY BE IN FULL SWING TO PROTECT YOU WHEN WE SEE AN EXPECTED SPIKE IN DECEMBER OR JANUARY. ACCORDING TO THE CDC, 148 MILLION DOSES OF THE FLU VACCINE ARE IN SUPPLY. THIS SEASON, WITH MANY THAT ARE STEERING AWAY FROM FORMULAS THAT CONTAIN PRESERVATIVES. THE CDC, REMINDING THE PUBLIC CO-INFECTIONS, MEANING GETTING SEVERAL ILLNESSES ALL AT ONCE, IS NOT AN IMPOSSIBILITY, AND THE AID OF A VACCINATION HELPS ALLEVIATE HOW ILL THAT PERSON COULD BECOME. INFLUENZA VACCINE SAVE SO MANY LIVES THEY DECREASE THE RATE OF HOSPITALIZATIONS AND THEY DECREASE THE SEVERITY OF THE INFLUENZA VIRUS. LASTLY, A QUICK EXPLANATION AS TO WHY YOU CAN FEEL ACHY OR ILL AFTER GETTING THE SHOT. ANYTIME WE GET EITHER A VACCINE OR A VIRUS, OUR BODY IS GOING TO RESPOND VERY SIMILARLY TO TO TRY TO GET RID OF WHATEVER IS COMING IN THE BODY. SO THAT MAKES US HAVE MUSCLE ACHES. SOMETIMES YOU MIGHT GET A FEVER, YOU JUST MIGHT FEEL GENERALLY TIRED. THAT IS THE IMMUNE SYSTEM ACTIVATING AND DOING ITS JOB. BOTTOM LINE, DOCTORS SAY IT’S NEVER TOO LATE FOR THE FLU VACCINE, BUT FOR NEAR PERFECT TIMING FOR PEAK SEASON. NOW, IS YOUR SHOT IN SACRAMENTO ERIN HEFT KCRA THREE NEWS. AND WITH INSURANCE, THE VACCINE WILL LIKELY BE FREE OF CHARGE AND EVEN WITHOUT INSURANCE, THER

    Stay ahead this flu season: California health experts urge timely vaccinations

    The ideal time for the flu vaccine is before the end of October.

    As the cold weather sets in, flu season is expected to ramp up across the country.Experts, including Dr. Vanessa Walker, emphasize the importance of taking precautions now. “We’re not really seeing much flu at all yet in the hospitals or out in the community, it’s still at very low levels right now,” she explained. The ideal time for the flu vaccine is before the end of October, allowing it to reach full efficacy before the holiday season, when influenza cases typically peak.The Center for Disease Control and Prevention has ensured an ample supply of 148 million flu vaccine doses this year, many of which don’t include preservatives. Although its never too late to get vaccinated for influenza, if the virus is circulating, acting promptly maximizes protection.Dr. Walker provides insight into post-vaccination symptoms like muscle aches and fatigue, highlighting them as normal immune responses. Watch in the video player aboveSee more coverage of top California stories here | Download our app | Subscribe to our morning newsletter

    As the cold weather sets in, flu season is expected to ramp up across the country.

    Experts, including Dr. Vanessa Walker, emphasize the importance of taking precautions now.

    “We’re not really seeing much flu at all yet in the hospitals or out in the community, it’s still at very low levels right now,” she explained.

    The ideal time for the flu vaccine is before the end of October, allowing it to reach full efficacy before the holiday season, when influenza cases typically peak.

    The Center for Disease Control and Prevention has ensured an ample supply of 148 million flu vaccine doses this year, many of which don’t include preservatives.

    Although its never too late to get vaccinated for influenza, if the virus is circulating, acting promptly maximizes protection.

    Dr. Walker provides insight into post-vaccination symptoms like muscle aches and fatigue, highlighting them as normal immune responses. Watch in the video player above

    See more coverage of top California stories here | Download our app | Subscribe to our morning newsletter

    Source link

  • Pope Francis heads for Luxembourg and Belgium on a trip to a dwindling flock

    Pope Francis heads for Luxembourg and Belgium on a trip to a dwindling flock

    VATICAN CITY — VATICAN CITY (AP) — Pope Francis on Thursday began his trip to once-strong bastions of Christianity in the heart of Europe in an effort to reinvigorate a Catholic flock that is dwindling in the face of secular trends and abuse scandals that have largely emptied the continent’s magnificent cathedrals and village churches.

    Francis landed mid-morning Thursday in Luxembourg, the European Union’s second-smallest country, with a population of some 650,000 people, and its richest per capita. He arrived under stormy skies and blustery, damp conditions, days after the 87-year-old pope canceled his audiences because of a slight flu.

    Francis greeted journalists at the start of Thursday’s flight but declined to walk down the aisle to greet them one by one as he typically does. “I don’t feel up to the trip. I’ll greet you from here,” he said, referring to the trip down the aisle. The Vatican spokesman, Matteo Bruni, said the decision was due to the logistics of the aircraft, with just a single aisle, and the short duration of the flight, and was not a reflection of Francis’ health.

    After meeting with Luxembourg’s political leaders, Francis will speak to the country’s Catholic priests and nuns. The venue is the late-Gothic Cathedral of Notre Dame, which was built in the early 1600s by Francis’ own Jesuit order and stands as a monument to Christianity’s long and central place in European history.

    Francis is likely to dwell on Europe’s role past, present and future — particularly as war rages on European soil — during his visits to Luxembourg and Belgium, where he arrives later Thursday and stays through the weekend.

    The trip is a much-truncated version of the 10-day tour St. John Paul II made through Luxembourg, Belgium and the Netherlands in 1985, during which the Polish pope delivered 59 speeches or homilies and was greeted by hundreds of thousands of adoring faithful.

    In Luxembourg alone, John Paul drew a crowd of some 45,000 people to his Mass, or some 10% of the then-population, and officials had predicted a million people would welcome him in Belgium, according to news reports at the time.

    But then as now, the head of the Catholic Church faced indifference and even hostility to core Vatican teachings on contraception and sexual morals, opposition that has only increased in the ensuing generation. Those secular trends and the crisis over clergy abuse have helped lead to the decline of the church in the region, with monthly Mass attendance in the single digits and plummeting ordinations of new priests.

    Bruni said that by traveling to the two countries, Francis will likely want to offer “a word to the heart of Europe, of its history, the role it wants to play in the world in the future.”

    Immigration, climate change and peace are likely to be themes during the four-day visit, which was organized primarily to mark the 600th anniversary of the founding of Belgium’s two main Catholic universities.

    In Luxembourg, Francis has a top ally and friend in the lone cardinal from the country, Jean-Claude Hollerich, a fellow Jesuit.

    Hollerich, whom Francis made a cardinal in 2019, has taken on a leading role in the pope’s multi-year church reform effort as the “general rapporteur” of his big synod, or meeting, on the future of the Catholic Church.

    In that capacity, Hollerich has helped oversee local, national and continental-wide consultations of rank-and-file Catholics and synthesized their views into working papers for bishops and other delegates to discuss at their Vatican meetings, the second session of which opens next week.

    Last year, in another sign of his esteem for the progressive cardinal, Francis appointed Hollerich to serve in his kitchen cabinet, known as the Council of Cardinals. The group of nine prelates from around the globe meets several times a year at the Vatican to help Francis govern.

    __

    Casert reported from Brussels. AP researcher Rhonda Shafner contributed from New York.

    ___

    Associated Press religion coverage receives support through the AP’s collaboration with The Conversation US, with funding from Lilly Endowment Inc. The AP is solely responsible for this content.

    Source link

  • The Bird Flu Outbreak Takes a Mysterious Turn

    The Bird Flu Outbreak Takes a Mysterious Turn

    This year in the United States, 14 people have tested positive for avian influenza, or bird flu. Nine of those became infected after coming into contact with poultry, and four got the virus from exposure to dairy cows. The source of the remaining, most recent case remains a mystery.

    The Centers for Disease Control and Prevention confirmed the case on September 6. Initially detected by the Missouri Department of Health and Senior Services, it is the first known case of human bird flu in the country with no known exposure to a sick or infected animal. On Thursday, health officials said they hadn’t determined how the person acquired the virus.

    “Right now, evidence points to this being a one-off case,” said Nirav Shah, the CDC’s principal deputy director, during a news briefing.

    Yet the case is troubling, because it raises the possibility of an alternate source of transmission, either from a person or an unknown source. Health officials say there is no evidence of person-to-person spread at this time. The CDC says its surveillance system has not picked up any unusual flu activity in the country, and the risk to the general public remains low.

    “Our influenza surveillance system is designed to find needles in haystacks,” Shah said in the briefing. “In this case, we found such a needle, but we don’t know how it got there.”

    The Missouri case is the first to be detected through the country’s national flu surveillance system as opposed to targeted testing of animals. This year, the H5N1 flu virus has been responsible for wiping out poultry flocks across the country and infecting 200 dairy herds in 14 states—the latest in California. It is increasingly spilling over to other mammals, including foxes, mice, raccoons, and domestic cats. With more animals harboring the virus, there is greater potential for human infection.

    It’s not known whether that happened in the Missouri case, but it is one avenue health officials say they are investigating.

    “Regardless of the source, it’s concerning, because it suggests that there’s a lot of the virus out there,” says David Boyd, a virologist at UC Santa Cruz who studies influenza. “This indicates that there is widespread transmission among animal sources.”

    On August 22, an adult patient was hospitalized in Missouri for reasons related to underlying medical conditions and happened to also test positive for influenza. The patient’s specimen was then sent to the Missouri State Public Health Laboratory, which determined that it didn’t match the currently circulating seasonal flu viruses.

    That triggered additional testing by the CDC, which last week confirmed it was a type of bird flu, or H5. The agency was conducting additional testing to determine the virus subtype—the “N” part of H5N1. On Thursday, health officials said the patient had a very low concentration of viral genetic material and, because of this, they have not been able to generate a full genome, including the N part of the virus. However, their data shows that the specimen is closely related to the H5 virus circulating in dairy cows.

    Emily Mullin

    Source link

  • US Government Awards Moderna $176 Million for mRNA Bird Flu Vaccine

    US Government Awards Moderna $176 Million for mRNA Bird Flu Vaccine

    The US government will pay Moderna $176 million to develop an mRNA vaccine against a pandemic influenza—an award given as the highly pathogenic bird flu virus H5N1 continues to spread widely among US dairy cattle.

    The funding flows through BARDA, the Biomedical Advanced Research and Development Authority, as part of a new Rapid Response Partnership Vehicle (RRPV) Consortium. The program is intended to set up partnerships with industry to help the country better prepare for pandemic threats and develop medical countermeasures, the Department of Health and Human Services said in a press announcement Tuesday.

    In its own announcement on Tuesday, Moderna noted that it began a Phase 1/2 trial of a pandemic influenza virus vaccine last year, which included versions targeting H5 and H7 varieties of bird flu viruses. The company said it expects to release the results of that trial this year and that those results will direct the design of a Phase 3 trial, anticipated to begin in 2025.

    The funding deal will support late-stage development of a “prepandemic vaccine against H5 influenza virus,” Moderna said. But the deal also includes options for additional vaccine development in case other public health threats arise.

    “mRNA vaccine technology offers advantages in efficacy, speed of development, and production scalability and reliability in addressing infectious disease outbreaks, as demonstrated during the Covid-19 pandemic,” Moderna CEO Stéphane Bancel said in the announcement. “We are pleased to continue our collaboration with BARDA to expedite our development efforts for mRNA-based pandemic influenza vaccines and support the global public health community in preparedness against potential outbreaks.”

    US health officials have said previously that they were in talks with Moderna and Pfizer about the development of a pandemic bird flu vaccine. The future vaccine will be in addition to standard protein-based bird flu vaccines that are already developed. In recent weeks, the health department has said it is working to manufacture 4.8 million vials of H5 influenza vaccine in the coming months. The plans come three months into the H5N1 dairy outbreak, which is very far from the initial hopes of containment.

    Botched Response

    The US is badly fumbling its response to the unprecedented outbreak, drawing criticism from US-based and international experts alike. Genetic analyses suggest that the virus has been spreading among the country’s dairy cattle since late last year. But it wasn’t until months later, on March 25, that the US Department of Agriculture confirmed the first four infected herds in two states (Texas and Kansas). Since then, the outbreak has spread to around 140 herds in 12 states—at least.

    Some farms are refusing to test, and experts expect that there is a significant number of undocumented herd infections, particularly given the widespread detection of inactivated H5N1 in the commercial milk supply. Furthermore, of the 140 herds with documented infections, federal officials do not know how many are still actively infected rather than recovered. It is unclear whether infected cows can become reinfected, and if so, how quickly after an infection.

    While the risk to the general public is considered to be low currently, farm workers are at higher risk of contracting the infection. To date, there have been three confirmed infections among dairy farm workers—one in Texas and two in Michigan, which has had a uniquely robust response to the outbreak. Still, with hundreds to thousands of farm workers at risk of contracting the virus, only 53 people in the country to date have been tested for H5 influenza.

    Beth Mole, Ars Technica

    Source link

  • Bird flu is highly lethal to some animals, but not to others. Scientists want to know why

    Bird flu is highly lethal to some animals, but not to others. Scientists want to know why

    NEW YORK — In the last two years, bird flu has been blamed for the deaths of millions of wild and domestic birds worldwide. It’s killed legions of seals and sea lions, wiped out mink farms, and dispatched cats, dogs, skunks, foxes and even a polar bear.

    But it seems to have hardly touched people.

    That’s “a little bit of a head scratcher,” although there are some likely explanations, said Richard Webby, a flu researcher at St. Jude Children’s Research Hospital in Memphis, Tennessee. It could have to do with how infection occurs or because species have differences in the microscopic docking points that flu viruses need to take root and multiply in cells, experts say.

    But what keeps scientists awake at night is whether that situation will change.

    “There’s a lot we don’t understand,” said Dr. Tom Frieden, a former CDC director who currently heads Resolve to Save Lives, a not-for-profit that works to prevent epidemics. “I think we have to get over the ‘hope for the best and bury our head in the sand’ approach. Because it could be really bad.”

    Some researchers theorize that flu viruses that originated in birds were the precursors to terrible scourges in humans, including pandemics in 1918 and 1957. Those viruses became deadly human contagions and spread in animals and people.

    A number of experts think it’s unlikely this virus will become a deadly global contagion, based on current evidence. But that’s not a sure bet.

    Just in case, U.S. health officials are readying vaccines and making other preparations. But they are holding off on bolder steps because the virus isn’t causing severe disease in people and they have no strong evidence it’s spreading from person to person.

    The flu that’s currently spreading — known as H5N1 — was first identified in birds in 1959. It didn’t really begin to worry health officials until a Hong Kong outbreak in 1997 that involved severe human illnesses and deaths.

    It has caused hundreds of deaths around the world, the vast majority of them involving direct contact between people and infected birds. When there was apparent spread between people, it involved very close and extended contact within households.

    Like other viruses, however, the H5N1 virus has mutated over time. In the last few years, one particular strain has spread alarmingly quickly and widely.

    In the United States, animal outbreaks have been reported at dozens of dairy cow farms and more than 1,000 poultry flocks, according to the U.S. Department of Agriculture. Four human infections have been reported among the hundreds of thousands of people who work at U.S. poultry and dairy farms, though that may be an undercount.

    Worldwide, doctors have detected 15 human infections caused by the widely circulating bird flu strain. The count includes one death — a 38-year-old woman in southern China in 2022 — but most people had either no symptoms or only mild ones, according to the U.S. Centers for Disease Control and Prevention.

    There’s no way to know how many animals have been infected, but certain creatures seem to be getting more severe illnesses.

    Take cats, for example. Flu is commonly thought of as a disease of the lungs, but the virus can attack and multiply in other parts of the body too. In cats, scientists have found the virus attacking the brain, damaging and clotting blood vessels and causing seizures and death.

    Similarly gruesome deaths have been reported in other animals, including foxes that ate dead, infected birds.

    The flu strain’s ability to lodge in the brain and nervous system is one possible reason for “higher mortality rate in some species,” said Amy Baker, an Iowa-based U.S. Department of Agriculture scientist who studies bird flu in animals. But scientists “just don’t know what the properties of the virus or the properties of the host are that are leading to these differences,” Baker said.

    Unlike cats, cows have been largely spared. Illnesses have been reported in less than 10% of the cows in affected dairy herds, according to the USDA. Those that did develop symptoms experienced fever, lethargy, decreased appetite and increased respiratory secretions.

    Cow infections largely have been concentrated in the udders of lactating animals. Researchers investigating cat deaths at dairy farms with infected cows concluded the felines caught the virus from drinking raw milk.

    Researchers are still sorting out how the virus has been spreading from cow to cow, but studies suggest the main route of exposure is not the kind of airborne droplets associated with coughing and sneezing. Instead it’s thought to be direct contact, perhaps through shared milking equipment or spread by the workers who milk them.

    Then there’s the issue of susceptibility. Flu virus need to be able to latch onto cells before they can invade them.

    “If it doesn’t get into a cell, nothing happens. … The virus just swims around,” explained Juergen Richt, a researcher at Kansas State University.

    But those docking spots — sialic acid receptors — aren’t found uniformly throughout the body, and differ among species. One recent study documented the presence of bird flu-friendly receptors in dairy cattle mammary glands.

    Eye redness has been a common symptom among people infected by the current bird flu strain. People who milk cows are eye level with the udders, and splashes are common. Some scientists also note that the human eye has receptors that the virus can bind to.

    A study published this month found ferrets infected in the eyes ended up dying, as the researchers demonstrated that the virus could be as deadly entering through the eyes as through the respiratory tract.

    Why didn’t the same happen in the U.S. farmworkers?

    Some experts wonder whether people have some level of immunity, due to past exposure to other forms of flu or to vaccinations. However, a study in which human blood samples were exposed to the virus indicated there’s little to no existing immunity to this version of the virus, including among people who’d had seasonal flu shots.

    A more menacing question: What happens if the virus mutates in a way that makes it more lethal to people or allows it to spread more easily?

    Pigs are a concern because they are considered ideal mixing vessels for bird flu to potentially combine with other flu viruses to create something more dangerous. Baker has been studying the current strain in pigs and found it can replicate in the lungs, but the disease is very mild.

    But that could all change, which is why there’s a push in the scientific community to ramp up animal testing.

    Frieden, of Resolve to Save Lives, noted public health experts have been worried about a deadly new flu pandemic for a long time.

    “The only thing predictable about influenza is it’s unpredictable,” he said.

    ___

    The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.

    Source link

  • What women should know about Medicare coverage for health screenings and exams

    What women should know about Medicare coverage for health screenings and exams

    As women get older, our risk for certain chronic diseases increase. We can thank the aging process itself, and the loss of estrogen’s protective effects after menopause. Older women are more prone to conditions like osteoporosis, which can cause brittle bones. The chance of heart disease rises, as do the odds of developing dementia, in part because women tend to live longer than men, and risk increases with age.

    Diagnosing some conditions is more challenging, since the frequency, appearance and long term effects of many diseases often appear differently in women than in men. It’s a key reason not to neglect regular health screenings and wellness visits, since staying healthier through preventive care and screenings can make the health challenges of aging easier.

    Wellness exams are critical for older women

    Medicare pays for annual preventive care with no co-pay. That’s especially relevant for women, who made up more than half (55%) of all Medicare beneficiaries in 2021. Nearly 1 in 8 (12%) were 85 or older; many had functional difficulties, an analysis from KFF found. That included difficulty walking, bathing, vision loss, or other issues that significantly impacted their quality of life. People age 85 and older tend to have five or more chronic conditions, which can become more complicated to manage with age.

    Women know they should focus on their health, says Alina Salganicoff, director of women’s health policy at KFF. But, “sometimes the system is not set up for women to take care of themselves, because they have competing demands, like work, or family caregiving responsibilities.” This often creates limited windows of time for women to prioritize themselves.

    And, if women don’t have access to a primary care provider or don’t receive regular care, they could skip important preventive measures like mammograms, she says.

    “Having coverage is the first step, but many other factors affect whether women get the services they need,” Salganicoff says. That includes their relationships with their clinicians, their own prior experiences, access to care, fears about conditions like dementia or cancer, or social supports like transportation, mobility or cognitive issues, or having someone to accompany them.

    That first wellness visit is probably key to everything else in managing an older patient, according to Segen Chase, an internal medicine physician in private practice in Manhattan, Kansas. About 35% of her clinic’s patients are Medicare beneficiaries, including many who live at a nearby retirement community.

    “It’s so important that we will do anything we can to have them visit and work with the practice’s wellness coordinator to go through all of the needed assessments,” said Chase, who is part of the American Medical Women’s WEL leadership training program.

    Wellness exams include annual tracking of numerous behavioral and physical markers like vision, hearing, fall risk, sexual health, nutrition, alcohol and tobacco use, as well as psychosocial risks like depression, stress, loneliness or social isolation, pain, and fatigue. Patients also undergo cognitive screening, which can reveal subtle changes in brain health.

    Wellness screenings may also include questions about someone’s living situation, because it helps us to determine whether they might need additional help at home, Chase says. “That also gives us an opportunity to discuss advance care planning, when they’re not in a crisis situation.” Medicare pays for this as part of the Part B annual wellness visit.

    Women with Medicare overall experience higher rates of certain health conditions compared to men, according to the KFF analysis. Urinary incontinence (37% vs. 18%), depression (31% vs. 21%), osteoporosis (29% vs. 7%), and pulmonary disease (20% vs. 16%) were more common among women than men. Women are also more likely than men to live alone. More than one-third of all women with Medicare (36%) live by themselves and more than half of those 85 and older live solo. This can increase the odds of  loneliness and social isolation, which are connected to increased risk of depression, dementia and stroke, according to the American Medical Association.

    The wellness visit can help uncover some of the hidden issues, and together, the physician and patient can create a care plan to manage these and other chronic conditions, Chase says.

    Which preventive women’s health services does Medicare cover?

    Medicare Part B covers a range of preventive services that benefit women’s health, including:

    There are no copays, deductibles or coinsurance charges for these and other covered screenings, although certain other criteria may apply, according to the Medicare Rights Center. Medicare Part A (hospital insurance) and Medicare Part B (medical insurance) will even help pay for an osteoporosis injectable drug and visits by a home health nurse to inject the drug if you are eligible.

    This partial list of Medicare-covered screenings may seem daunting, which is why it’s so important for women to speak with their clinicians and discuss their health history, risk factors, and priorities, according to Salganicoff. “It’s a complicated program and can be difficult for people to navigate,” she says.

    These shouldn’t be one-off conversations, either, Chase says. As we age, priorities and what is realistic for a person to achieve may shift. So ongoing dialogue is a key to maintaining health.

    We know certain conditions show up differently in women, so “a lot of medicine comes back to communication, keeping the sanctity of the relationship while honoring their independence and finding out what’s most important to that person,” she says. Chase finds these discussions help women open up more about both their physical and emotional challenges, especially those who are caregivers. “They’re often exhausted but don’t want to admit it.”

    Providing women with clear, simple information so they can learn about all of their Medicare benefits and receive the necessary support to get the preventive care and other needed services, can go a long way towards keeping women healthy well into older age.

    Liz Seegert

    Source link

  • How to Make a “Medicine Ball,” Starbucks’s Slightly Controversial Tea Drink – POPSUGAR Australia

    How to Make a “Medicine Ball,” Starbucks’s Slightly Controversial Tea Drink – POPSUGAR Australia

    When you’re searching for relief from the discomfort of a cold or the flu, you likely hit up the drugstore’s cold and flu aisle. But at least some people also swing by their local Starbucks for a semi-controversial, cult-favorite drink. Yes, we’re talking about the Starbucks “Medicine Ball,” a soothing tea blend that has garnered a loyal following for its comforting effects.

    We’re believers that the best forms of relief come from the most unexpected places, and that anything that offers a glimmer of comfort amidst the discomfort of sickness is worth its weight in gold. The only problem with the Starbucks Medicine Ball drink is that you have to leave your house to get it – and, if you’re drinking it because you’re not feeling well, that means potentially exposing the hard-working baristas to your germs. With that in mind, we pulled together a Starbucks Medicine Ball recipe, to help you recreate the soothing comfort in the safety of your own home.

    What’s In a Starbucks Medicine Ball?

    Firstly, it’s crucial to point out that the Starbucks Medicine Ball does not contain actual medicine. At Starbucks, the drink is officially known as Honey Citrus Mint Tea. The menu states it was a popular customer creation that ended up on the regular menu. The soothing beverage combines Jade Citrus Mint green tea, Peach Tranquility herbal tea (a tea made with sweet peach, pineapple, chamomile blossoms, and lemon verbena), hot water, steamed lemonade, and honey.

    This drink does contain a small amount of caffeine, as it is made with a green tea which naturally contains this stimulant. But the overall caffeine level of this drink is relatively low compared to other Starbucks beverages, making it a comforting choice for those looking for a warm, soothing option with a hint of a caffeine pick-me-up.

    And while, again, the Starbucks Medicine Ball does not contain any true medicine, some people find that consuming honey helps ease their sore throat somewhat, while mint may help clear congestion temporarily.

    How To Order the Starbucks “Medicine Ball” Drink

    To order a Medicine Ball at Starbucks, simply approach the counter and ask for a Honey Citrus Mint Tea, the drink’s official name. If desired, you can customize your tea drink by asking for more or less lemonade and/or honey if you want it sweeter or not-as-sweet.

    A word of warning: some baristas aren’t huge fans of the Starbucks Medicine Ball, as evidenced by several Reddit threads like this one. The main complaint seems to be its popularity among sick people, who put baristas’ health at risk by coming into stores in person to order the drink. So keep in mind that if you are sick and contagious, you may not be considered the kindest patron if you’re prancing into a crowded Starbucks store, sniffling and sneezing – potentially exposing other customers to your illness. If you’re sick and you want to enjoy this drink, send a friend to snag one for you, hit up the drive-through (while wearing a mask), or make our Starbucks Medicine Ball recipe at home instead.

    Related: Is It Rude to Lie About Being Sick? And 21 Other Illness Etiquette Questions

    Starbucks Medicine Ball Tea Recipe

    To recreate the soothing Starbucks Medicine Ball tea at home, you’ll need the following ingredients:

    • 1 bag of Teavana Jade Citrus Mint Green Tea
    • 1 bag of Teavana Peach Tranquility Herbal Tea
    • 8 ounces of hot water
    • 8 ounces of steamed lemonade
    • 1 tablespoon of honey

    Steps:

    1. Heat your water to a near-boil and pour 8 ounces into a mug.
    2. Add both tea bags to the mug and allow them to steep for about 3-5 minutes.
    3. While the tea is steeping, heat your lemonade. You can do this by either heating it on the stove or by using a microwave. Aim for it to be hot but not boiling.
    4. Remove the tea bags from the mug, ensuring to squeeze them gently to extract the flavorful tea without releasing bitterness.
    5. Add the hot lemonade to your mug with the steeped tea.
    6. Stir in a tablespoon of honey, adjusting according to your sweetness preference.
    7. Enjoy your homemade Starbucks Medicine Ball, perfect for soothing a sore throat or just warming up on a chilly day.

    If you don’t have access to Teavana teas, you can use other brands of green tea, mint tea, and peach tea to recreate this concoction. And if you don’t have lemonade on hand, a healthy squeeze of lemon juice can do in a pinch, although you may need to increase the amount of water and honey you use to compensate.

    Then, sip and enjoy the soothing sensation. Ahhh…


    Lauren Manaker is an award-winning registered dietitian and freelance writer who is passionate about providing evidence-based nutrition information in a fun and interesting way.


    Lauren manaker

    Source link